BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36709328)

  • 1. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
    Mi YY; Ji Y; Zhang L; Sun CY; Wei BB; Yang DJ; Wan HY; Qi XW; Wu S; Zhu LJ
    Cell Death Dis; 2023 Jan; 14(1):67. PubMed ID: 36709328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
    Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
    Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBO1 induces histone acetylation and is important for non-small cell lung cancer cell growth.
    Chen TF; Hao HF; Zhang Y; Chen XY; Zhao HS; Yang R; Li P; Qiu LX; Sang YH; Xu C; Liu SX
    Int J Biol Sci; 2022; 18(8):3313-3323. PubMed ID: 35637972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBO1 overexpression is important for hepatocellular carcinoma cell growth.
    Zhong W; Liu H; Deng L; Chen G; Liu Y
    Cell Death Dis; 2021 May; 12(6):549. PubMed ID: 34039960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBO1 (KAT7) Does Not Have an Essential Role in Cell Proliferation, DNA Replication, or Histone 4 Acetylation in Human Cells.
    Kueh AJ; Eccles S; Tang L; Garnham AL; May RE; Herold MJ; Smyth GK; Voss AK; Thomas T
    Mol Cell Biol; 2020 Jan; 40(4):. PubMed ID: 31767635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia.
    Wang H; Qiu Y; Zhang H; Chang N; Hu Y; Chen J; Hu R; Liao P; Li Z; Yang Y; Cen Q; Ding X; Li M; Xie X; Li Y
    Cell Death Dis; 2023 Aug; 14(8):498. PubMed ID: 37542030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling.
    Huang SH; Tseng JC; Lin CY; Kuo YY; Wang BJ; Kao YH; Muller CJF; Joubert E; Chuu CP
    Phytomedicine; 2019 Nov; 64():153068. PubMed ID: 31419729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.
    Chen Z; Jiang Q; Zhu P; Chen Y; Xie X; Du Z; Jiang L; Tang W
    Prostate; 2019 Jan; 79(1):44-53. PubMed ID: 30178500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
    Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
    J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
    Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
    Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
    Zhou X; Zou L; Chen W; Yang T; Luo J; Wu K; Shu F; Tan X; Yang Y; Cen S; Li C; Mao X
    Pharmacol Res; 2021 Feb; 164():105305. PubMed ID: 33197601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
    Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
    Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
    Shi SJ; Wang LJ; Han DH; Wu JH; Jiao D; Zhang KL; Chen JW; Li Y; Yang F; Zhang JL; Zheng GX; Yang AG; Zhao AZ; Qin WJ; Wen WH
    Theranostics; 2019; 9(5):1247-1263. PubMed ID: 30867828
    [No Abstract]   [Full Text] [Related]  

  • 16. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
    Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
    PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
    J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
    Kang M; Lee KH; Lee HS; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2017; 12(9):e0184644. PubMed ID: 28910332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
    Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.